For the second time in the past year, the lower house of the Chilean congress passed a resolution instructing the government to make it possible to issue compulsory licenses for medicines, but this time, the effort is focused specifically on hepatitis C treatments.

The move comes in response to concerns over rising prices and the ability of the government to cover costs, according to the resolution, and follows a move last month by more than two dozen advocacy groups from around the world to press the health ministry to take action.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Forgive stupid question, but why is no login for my Stat+ subscription possible on Safari on my iPad? Seriously, nowhere on page is there a log-in. Browsers on laptop all work fine but not ipad. Thanks for any help.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy